CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $86.2 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.41. Losses, adjusted to account for discontinued operations, came to $1.36 per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.39 per share.

Agios Pharmaceuticals shares have climbed 15% since the beginning of the year. The stock has dropped 2.5% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News